Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 1—January 2009

Linezolid-Resistant Staphylococcus cohnii, Greece

Efi PetinakiComments to Author , Maria Kanellopoulou, Anthi Damani, Antigoni Foka, Iris Spiliopoulou, Nikoletta Skalmoutsou, Bogdan Raitsiou, Konstantinos Valakis, and Evangelos Papafragas
Author affiliations: University of Thessalia, Larissa, Greece (E. Petinaki); Sismanoglion General Hospital of Athens, Athens, Greece (M. Kanellopoulou, N. Skalmoutsou, B. Raitsiou, K.Valakis, E. Papafragas); Institute of BioMedical Research and Technology, Larissa (E. Petinaki, A. Damani); University of Patras, Patras, Greece (A. Foka, I. Spiliopoulou)

Main Article


Clinical characteristics of 4 patients from whom linezolid-resistant Staphylococcus cohnii was isolated, Greece, 2007*

Patient no. Gender/ age, y Medical
history Reason
for hospitalization Previous treatment Date of hospital admission Date of sample collection Outcome Date of death or discharge
1 F/82 No relevant history Acute cholecystitis, necrotizing pancreatitis CIP, CAZ, IMP, TZP, LIN May 10 Jul 20 Death Aug 21
2 M/38 Alcoholism Lung abscess CIP, CAZ, LIN Jul 14 Aug 21 Recovery Oct 20
3 M/52 COPD, melitensus diabetes Necrotizing pneumonia TZP, CLI, IMP, LIN Aug 21 Sep 25 Recovery Oct 30
4 M/65 No relevant history Septic shock IMP, CIP, TZP, LIN Sep 17 Oct 28 Recovery Dec 10

*CIP, ciprofloxacin; CAZ, ceftazidime; IMP, imipenem; TZP, piperacillin-tazobactam; LIN, linezolid; CLI, clindamycin; COPD, chronic obstructive pulmonary disease.

Main Article

Page created: December 06, 2010
Page updated: December 06, 2010
Page reviewed: December 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.